Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate

被引:31
|
作者
Innocenti, A [1 ]
Vullo, D [1 ]
Scozzafava, A [1 ]
Supuran, CT [1 ]
机构
[1] Univ Florence, Chim Bioorgan Lab, I-50019 Sesto Fiorentino, Firenze, Italy
关键词
D O I
10.1016/j.bmcl.2004.11.056
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The inhibition of five human carbonic anhydrase (hCA, EC 4.2.1.1) isozymes; the cytosolic hCA I and II, the membrane-bound hCA IV. the mitochondrial hCA V, and the tumor-associated, transmembrane hCA IX, with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate; such as chlorate, perchlorate, bromate, iodate, periodate, silicate, bismuthate, vanadate, molybdate, and wolframate is reported. Apparently, the geometry of the inhibitor (tetrahedral or trigonal) does not influence its binding to the Zn(II) ion of the enzyme active site, but the nature of the central element is the most important factor influencing potency. Isozymes hCA I and II are best inhibited by chlorate, perchlorate, and silicate, together with the anions structurally related to sulfate, sulfamate, and sulfamidate, but sulfate itself is a weak inhibitor (inhibition constant of 74 mM against hCA I and 183 mM against hCA II). Molybdate is a very weak hCA I inhibitor (K-I of 914 mM) but it interacts with hCA II (K-I of 27.5 mM). Isozyme IV is well inhibited by sulfate (K-I of 9 mM), sulfamate, and sulfamidate (in the low micromolar range), but not by perchlorate (KI of 767 mM). The mitochondrial isozyme V has the lowest affinity for sulfate (KI of 680 mM) and carbonate (K-I of 95 mM) among all the investigated isozymes, suggesting on one hand its possible participation in metabolon(s) with sulfate anion exchanger(s), and on the other hand an evolutionary adaptation to working at higher pH values (around 8.5 in mitochondria) where rather high amounts of carbonate in equilibrium with bicarbonate may be present. Metasilicate, isosteric to carbonate, is also about a 10 times weaker inhibitor of this isozyme as compared to other CAs investigated here (K-I of 28.2 mM). Surprisingly, the tumor-associated isozyme IX is resistant to sulfate inhibition (K-I of 154 mM) but has affinity in the low micromolar range for carbonate, sulfamate, and sulfamidate (K-I in the range of 8.6-9.6 muM). This constitutes another proof that this isozyme best works at acidic pH values present in tumors, being inhibited substantially at higher pH values when more carbonate may be present. Bromate and chlorate are quite weak CA IX inhibitors (KI s of 147-274 mM). (C) 2004 Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:567 / 571
页数:5
相关论文
共 50 条
  • [41] Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII, and XIV with less investigated anions including trithiocarbonate and dithiocarbamate
    Innocenti, Alessio
    Scozzafava, Andrea
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (05) : 1548 - 1550
  • [42] Benzenesulfonamides with trisubstituted triazole motif as selective carbonic anhydrase I, II, IV, and IX inhibitors
    Sharma, Vikas
    Kumar, Rajiv
    Angeli, Andrea
    Supuran, Claudiu T.
    Sharma, Pawan K.
    ARCHIV DER PHARMAZIE, 2023, 356 (01)
  • [43] First evaluation of organotellurium derivatives as carbonic anhydrase I, II, IV, VII and IX inhibitors
    Angeli, Andrea
    Tanini, Damiano
    Capperucci, Antonella
    Supuran, Claudiu T.
    BIOORGANIC CHEMISTRY, 2018, 76 : 268 - 272
  • [44] Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide
    Cecchi, A
    Winum, JY
    Innocenti, A
    Vullo, D
    Montero, JL
    Scozzafava, A
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (23) : 5775 - 5780
  • [45] Carbonic Anhydrase Inhibitors: Inhibition of Human Erythrocyte Isozymes I and II with a Series of Phenolic Acids
    Sarikaya, S. Beyza Oeztuerk
    Gulcin, Ilhami
    Supuran, Claudiu T.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2010, 75 (05) : 515 - 520
  • [46] Carbonic anhydrase inhibitors:: Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with benzo[b]thiophene 1,1-dioxide sulfonamides
    Innocenti, A
    Villar, R
    Martinez-Merino, V
    Gll, MJ
    Scozzafava, A
    Vullo, D
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (21) : 4872 - 4876
  • [47] Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives
    Brzozowski, Zdzislaw
    Slawinski, Jaroslaw
    Gdaniec, Maria
    Innocenti, Alessio
    Supuran, Claudiu T.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (09) : 4403 - 4410
  • [48] QSAR studies of sulfamate and sulfamide inhibitors targeting human carbonic anhydrase isozymes I, II, IX and XII
    Tarko, Laszlo
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (06) : 1404 - 1409
  • [49] Novel aromatic/heterocyclic sulfonamides and their metal complexes as inhibitors of carbonic anhydrase isozymes I, II and IV
    Supuran, CT
    Scozzafava, A
    JOURNAL OF ENZYME INHIBITION, 1997, 12 (01): : 37 - 51
  • [50] Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties
    Garaj, V
    Puccetti, L
    Fasolis, G
    Winum, JY
    Montero, JL
    Scozzafava, A
    Vullo, D
    Innocenti, A
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (21) : 5427 - 5433